ibuprofen has been researched along with Blindness in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
Excerpt | Relevance | Reference |
---|---|---|
"A follow-up study of 99 infants with birth weight ≤ 1,500 g and gestational age ≤ 32 weeks who received either oral or intravenous ibuprofen for patent ductus arteriosus was conducted to assess at 18 to 24 months (corrected age), abnormal neurological, neurosensory, and cognitive impairment were defined as follows:neurological outcomes included moderate/severe cerebral palsy, neurosensory outcomes included bilateral hearing loss and blindness in either eye, and cognitive impairment included mental developmental index score < 70." | 5.17 | Impact of oral versus intravenous ibuprofen on neurodevelopmental outcome: a randomized controlled parallel study. ( Dilmen, U; Eras, Z; Erdeve, O; Gokmen, T; Ozyurt, BM; Saridas, B, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eras, Z | 1 |
Gokmen, T | 1 |
Erdeve, O | 1 |
Ozyurt, BM | 1 |
Saridas, B | 1 |
Dilmen, U | 1 |
1 trial available for ibuprofen and Blindness
Article | Year |
---|---|
Impact of oral versus intravenous ibuprofen on neurodevelopmental outcome: a randomized controlled parallel study.
Topics: Administration, Intravenous; Administration, Oral; Blindness; Case-Control Studies; Cerebral Palsy; | 2013 |